Featured Video Play Icon

Journal Club July 2018: an update on new drugs for Bladder Pain Syndrome/Interstitial Cystitis

I like to keep up to date with the emerging evidence, so every few months I do a literature search for things I’ve not seen or missed before. Here are two papers from 2017 covering different potential medications for BPS that I found interesting, and not necessarily for what you may initially think.

I love it when clinical trial failure is published, it always teaches us much more than outright success. If only more failure was shared!

Here are the references:

Wang. H, Russell. J, Kelly. K, Wang. S, Thipphawong. J. (2017) Fulranumab in patients with interstitial cystitia/bladder pain syndrome: observations from a randomized, double-blind, placebo controlled study. BMC Urology, 17:2.

Lim. Y, Dwyer. P, Murray. C, Karmakar. D, Rosamilia. A, Thomas. E. (2017) Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 28:1085-1089


If you’re interested in talking to me I have a clinic in Cardiff and also see people via Skype sessions. Click here to book yourself some time with me.

If you want to keep in the loop subscribe to my newsletter and you’ll receive a FREE infographic as well as all my latest vlogs, freebies, course information and catch up with what’s happening in the world of pelvic pain research. Feel free to print and use the infographic in your clinic or online marketing with clients. (Don’t worry, you won’t be bombarded with marketing, this is about sharing knowledge and working together to improve the treatment of those with pelvic issues.) You can find more information about my data privacy policy here.